Evidence map›Paper›PMID 42245793›Full record

ArticleResearch square2026

SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancer.

Aanika B Warner, Britanny B Solarz, Miroslava Belyov, Valentina Bolanos, Ann McCoy, Takeo Fujii, Jung-Min Lee, Kevin Conlon, Mireya Gomez, Bernadette Redd and 13 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Aanika B WarnerNational Cancer Institute.
Britanny B SolarzNational Cancer Institute.
Miroslava BelyovNational Cancer Institute.
Valentina BolanosNational Cancer Institute.
Ann McCoyNational Cancer Institute.
Takeo FujiiNational Cancer Institute.
Jung-Min LeeNational Cancer Institute.
Kevin ConlonNational Cancer Institute.
Mireya GomezNational Cancer Institute.
Bernadette ReddNational Institutes of Health.
Christopher A Febres-AldanaNational Cancer Institute.
Liqiang XiNational Cancer Institute.
Mark RaffeldNational Cancer Institute.
Ruchi PatelNational Cancer Institute.
Lisa CordesNational Cancer Institute.
William D FiggNational Cancer Institute.
Gal DinstagPangea Biomed.
Ranit AharonovPangea Biomed.
Tuvik BekerPangea Biomed.
Kenneth AldapeNational Cancer Institute.
Eytan RuppinNational Cancer Institute.
Stanley LipkowitzNational Cancer Institute.
Padma Sheila RajagopalNational Cancer Institute.

Funding

Identifying Treatment Options using RNA-Based Synthetic Lethality and RescueZIABC012058 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RAJAGOPAL, PADMA · 2021 to 2025
$653k
Intramural NIH HHS ZIA BC012058
6 · The paper itself

Abstract

SYNTHESIS-Breast is an exploratory trial that adapts early-phase design to identify off-label therapies in metastatic breast cancer via ENLIGHT, a retrospectively validated computational algorithm, and generate preliminary data for future trials. ENLIGHT selects treatments via gene-expression-based synthetic lethality/rescue. SYNTHESIS-Breast's design includes algorithm-specific adaptations (ex. a reproducible molecular tumor board or layered Simon two-stages for fast interim checkpoints). SYNTHESIS-Breast will not only guide ENLIGHT applications, but also future prospective algorithm trials.

Identifiers

PMID42245793
PMCPMC13232443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.